Company intelligence / Profile preview

Differential Labs

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Differential Bio has demonstrated its Virtual Scale-up Platform can significantly improve efficiency in industrial biotechnology. In one case study with a probiotics client transitioning from animal-based to plant-based media while maintaining performance metrics using the platform resulted in a fourfold increase in biomass yield and a 16% reduction in production costs. The company’s approach enables faster optimization cycles with less reliance on costly physical experiments.

Modalities: Microbial therapyRecombinant protein productionSmall molecule fermentation
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Differential Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Differential Labs.

Explore the full profile